C95.01
Acute leukemia of unspecified cell type, in remission
Clinical Classification Guidelines
Medical Intelligence & Overview
Acute leukemia of unspecified cell type, in remission, refers to a form of blood cancer characterized by the rapid growth of abnormal white blood cells in the bone marrow and bloodstream. When in remission, current treatments have successfully reduced cancer symptoms and signs, but close monitoring is essential as the risk of recurrence remains. This condition is classified under ICD-10 code C95.01 and encompasses cases where the exact type of leukemia cells hasn't been specifically identified, but the disease has responded well to treatment.
Causes & Symptoms
Clinical Causes: Genetic mutations in hematopoietic stem cells Exposure to radiation or certain chemotherapy drugs Environmental factors such as exposure to benzene or other chemicals Previous history of other blood disorders Inherited genetic disorders like Down syndrome or Li-Fraumeni syndrome Unknown causes in many cases, as with most leukemias
Key Symptoms: Fatigue and weakness Unintentional weight loss Fever or chills Frequent infections Easy bruising or bleeding tendencies Bone or joint pain Swollen lymph nodes, liver, or spleen Paleness and shortness of breath
Diagnostic & Treatment
Diagnosis Path: Diagnosing this type of leukemia involves several steps, primarily focusing on blood and bone marrow tests. The common diagnostic procedures include: - **Complete Blood Count (CBC):** to detect abnormal blood cell levels - **Bone marrow biopsy:** to examine the marrow directly for abnormal cells - **Flow cytometry:** to analyze the characteristics of blood cells - **Cytogenetic analysis:** to identify genetic abnormalities - **Molecular testing:** for specific gene mutations Because this leukemia is designated as 'unspecified cell type,' these tests also help rule out specific leukemia types and confirm the diagnosis of acute leukemia in remission.
Treatment Protocols: Even when in remission, ongoing management is crucial to maintain health and monitor for potential recurrence. Treatment strategies may include: - **Follow-up chemotherapy:** to eliminate remaining cancer cells - **Targeted therapies:** if genetic mutations are identified - **Immunotherapy:** to help boost the immune system's ability to fight cancer - **Stem cell transplant:** in some cases, especially if the risk of relapse is high - **Supportive care:** such as antibiotics for infections, transfusions for anemia, and growth factors to stimulate blood cell production Patients in remission should have regular medical assessments, including blood tests and bone marrow examinations, to ensure the disease remains controlled.
Clinical Advice & FAQs
Billing Guidance
Is C95.01 a billable ICD-10 code?
Yes, C95.01 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C95.01?
Clinical documentation must specify the nature of Acute leukemia of unspecified cell type, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
